Feb 3 (Reuters) - Atrys Health SA ATRY.MC :
* ON FEBRUARY 7 WILL BECOME EFFECTIVE THE DELISTING OF ALL
COMPANY'S SHARES FROM BME GROWTH AND THEIR SIMULTANEOUS
ADMISSION TO SPANISH STOCK EXCHANGE
* SPAIN'S REGULATOR HAS VERIFIED COMPLIANCE WITH NECESSARY
REQUIREMENTS FOR ADMISSION TO TRADING OF COMPANY ON STOCK
EXCHANGES OF MADRID, BARCELONA, BILBAO AND VALENCIA
* IT IS EXPECTED THAT FEBRUARY 4, 2022, WILL BE THE LAST DAY
OF
TRADING OF THE SHARES IN THE BME GROWTH SEGMENT OF BME MTF
EQUITY
Source text for Eikon: ID:nCNM3c1wyg
Further company coverage: ATRY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))